InvestorsHub Logo

BonelessCat

04/09/14 12:52 AM

#87181 RE: David Fowler #87158

Dr. Seymour hasn't been part of Saliva Diagnostics for 16 years. When he left it was trading at $2 a share. 20 years from start to present is hardly "straight to zero."

Ehrlich stepped in for one in for one year. At that point after other CEOs, not Seymour, ran it into the ground, it was too far gone to save or renew as a reverse merger for another start up.

Ehrlich then took another company, which was near bankrupt, and turned it around.

andia

04/09/14 9:46 AM

#87218 RE: David Fowler #87158

Oh really?

... Eugene Seymour....appears to have received law suits and multiple FDA warning

.
SO now, one of his drug candidates received orphan drug status. Does it tell you something ?????????????

FORZANANO

04/09/14 9:55 AM

#87220 RE: David Fowler #87158


Eugene Seymour and Leo Ehrlich's previous company "Saliva Diagnostics" seems to have essentially gone straight to zero and appears to have received law suits and multiple FDA warning letters5.



Prove it!

FN

MinnieM

04/09/14 2:43 PM

#87319 RE: David Fowler #87158

Seymour hasn't had anything to do with the management of Saliva Diagnostics in years. Same with Ehrlich. As a matter of fact, Ehrlich brought a company out of near bankruptcy that now has three ongoing human trials.

Shareholders here would do very well with the initiation of human trials. Seymour may yet pull it off. Time will tell.




In Reply to 'David Fowler'
Wise UP! The future of NNVC:

Eugene Seymour and Leo Ehrlich's previous company "Saliva Diagnostics" seems to have essentially gone straight to zero and appears to have received law suits and multiple FDA warning letters5. This defunct company now trades with ticker SSUR for $0.05 per share with $198k market cap (not a typo).




Smooth

08/05/14 1:54 PM

#96109 RE: David Fowler #87158

Regarding the PPS on SSUR while ES was the CEO, it does look like there were a couple of very very good trades in the 1995-1997 with the pps going from $2 to $10 twice.

The big long price decline on the chart you show happened long after ES was gone.

I expect that we'll see NUMEROUS trading opportunities with NNVC in the months ahead. I honestly can't say that the naysayers here are wrong, but I can't say that they are right either. There's been an awful lot of junk discovered about NNVC IMO, but there is still the possibility that the naysayer dots have been connected incorrectly and that this virus-neutralizing company is going to be a new paradigm. But trade I will!